Skip to content

KanSurvive: Testing a Model for Improving Cancer Survivorship Care in Rural Practice

KanSurvive: Testing a Model for Improving Cancer Survivorship Care in Rural Practice

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04763824
Acronym
KANSURVIVE
Enrollment
15
Registered
2021-02-21
Start date
2020-11-18
Completion date
2023-12-18
Last updated
2026-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer

Keywords

Cancer Survivorship, Rural Primary Care Practices

Brief summary

Approximately, 20 rural primary care practices to participate in a delayed intervention-controlled trial. Phase I: Formal and structured work flow evaluations to better identify specific gaps in processes of care while assessing what on-going training is needed for adoption of high-quality cancer survivorship care in rural practice. These will be incorporated into the ECHO sessions (Aim 1). Phase II: Conduct and test the effectiveness of the novel KanSurvive-ECHO intervention (Aim 2) and finally identify barriers and facilitators to implementation of KanSurvive-ECHO (Aim 3).

Detailed description

While evidence-based practice (EBP) guidelines exist for cancer survivorship care, implementation in rural practices has fallen short. Approximately 72.5% of Kansas cancer survivors who have completed their cancer treatment receive a majority of their health care from Primary Care Providers, yet these providers describe a lack of basic awareness of risk-based surveillance, effects of cancer treatment and their management, as well as inadequate resources, and growing administrative demands as reasons for not working to improve survivorship care. These factors may also prevent shared care management of cancer survivors between primary care and rural oncology care providers. There is a pressing need to understand primary care practice capacity to implement guideline informed management and follow-up for cancer survivors in the acute and extended phases of care. Specific Aim 1. Formally assess gaps in processes of care and additional training needed to result in actual adoption of high-quality care for acute and chronic survivors of breast, colorectal, lung, and prostate cancer in 20 rural primary care practices. Utilize this formative information to further refine the KanSurvive-ECHO. Specific Aim 2. Evaluate the effectiveness of KanSurvive-ECHO for enhancing evidence-based survivorship care for rural breast, colorectal, lung, and prostate cancer survivors. Hypothesis: Compared to delayed intervention control, rural primary care practices randomized to KanSurvive-ECHO will demonstrate greater concordance with evidence-based survivorship care guidelines as measured by a composition score determined by change in EHR documentation consistent with guideline concordant care. Specific Aim 3: Utilizing the Integrated Promoting Action on Research Implementation in Health Services (i-PARIHS) framework describe key facilitators and barriers to implementation of KanSurvive-ECHO including innovation, recipients, context, and facilitation. This novel project will provide a model for development of a community of practice using practice facilitation and Project ECHO to improve the management and follow-up of cancer survivors in the acute and extended phases of cancer survivorship.

Interventions

OTHERKanSurvive ECHO and Practice Facilitation

Four, 1-hour, virtual, case-based education sessions covering the evidence-based practice guidelines for breast, colorectal, lung, and prostate cancer survivorship care. Practice facilitation also provided to support participating primary care practices with quality improvement in the delivery of cancer survivorship care.

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
University of Kansas Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

Single-arm feasibility study aimed at evaluating the effectiveness of the KanSurvive ECHO intervention combined with practice facilitation to promote the adoption of evidence-based practice survivorship care guidelines.

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

1. Primary care practice (PCP) caring for rural cancer survivors 2. Willing to participate in four ECHO sessions 3. Capable and willing to complete pre- and post- data collection under a data use agreement 4. Cancer survivor data is eligible for extraction if the patient is a breast, prostate, lung, and/or colorectal cancer survivor and considered to have a reasonable likelihood of 24-month survival by a practice provider.

Exclusion criteria

1. PCPs unwilling to engage in project activities 2. PCPs with no rural-dwelling patients on their patient panel 3. Cancer survivor data is ineligible for extraction if the patient is \<18 years of age or \>75 years of age, is currently receiving hospice services, or has a history of cancer other than breast, prostate, lung, or colorectal.

Design outcomes

Primary

MeasureTime frameDescription
Tumor Surveillance Completion (Pre-Intervention)Baseline (Pre-Intervention) Chart AuditThis outcome reflects whether recommended tumor surveillance was completed and documented in the EHR. Tumor surveillance includes cancer-specific follow-up imaging consistent with evidence-based survivorship guidelines (e.g., NCCN, ASCO). Charts were coded as Completed if the recommended surveillance test was documented within the appropriate interval and Not Completed if documentation was absent, outdated, or incomplete. The outcome reports the proportion of EHR charts meeting tumor surveillance recommendations at baseline (pre-intervention) and again 24 months after the intervention.
Tumor Surveillance Completion (Post-Intervention)24-Month Follow-Up (Post-Intervention) Chart AuditThis outcome reflects whether recommended tumor surveillance was completed and documented in the EHR. Tumor surveillance includes cancer-specific follow-up imaging consistent with evidence-based survivorship guidelines (e.g., NCCN, ASCO). Charts were coded as Completed if the recommended surveillance test was documented within the appropriate interval and Not Completed if documentation was absent, outdated, or incomplete. The outcome reports the proportion of EHR charts meeting tumor surveillance recommendations at baseline (pre-intervention) and again 24 months after the intervention.
Distress Screening Completion (Pre-Intervention)Baseline (Pre-intervention) Chart ReviewThis outcome reflects whether recommended Distress Screening was completed and documented in the EHR. Distress Screening was defined as documentation of using a standardized distress assessment tool consistent with survivorship best practices. Charts were coded as Completed when a distress screening result was documented during the chart abstraction interval. Not Complete indicated missing or incomplete documentation.
Distress Screening Completion (Post-Intervention)24-Month Follow-Up (Post-Intervention) Chart AuditThis outcome reflects whether recommended Distress Screening was completed and documented in the EHR. Distress Screening was defined as documentation of using a standardized distress assessment tool consistent with survivorship best practices. Charts were coded as Completed when a distress screening result was documented during the chart abstraction interval. Not Complete indicated missing or incomplete documentation.
Body Mass Index (BMI) Assessment Completion (Pre-Intervention)Baseline (Pre-intervention) Chart ReviewBMI assessment was defined as documentation of a height and weight measurement sufficient to calculate body mass index (BMI) in the electronic health record (EHR). Charts were coded as Completed when BMI or its components were documented within the recommended timeframe.
Body Mass Index (BMI) Assessment Completion (Post-Intervention)24-Month Follow-Up (Post-Intervention) Chart AuditBMI assessment was defined as documentation of a height and weight measurement sufficient to calculate body mass index (BMI) in the electronic health record (EHR). Charts were coded as Completed when BMI or its components were documented within the recommended timeframe.
Tobacco Use Screening Completion (Pre-Intervention)Baseline (Pre-Intervention) Chart AuditTobacco use screening was defined as documentation of current tobacco use status in the electronic health record (EHR). Charts were coded as Completed when a screening result was documented within the recommended timeframe.
Tobacco Use Screening Completion (Post-Intervention)24-Month Follow-Up (Post-Intervention) Chart AuditTobacco use screening was defined as documentation of current tobacco use status in the electronic health record (EHR). Charts were coded as Completed when a screening result was documented within the recommended timeframe.
Cancer Diagnosis on Problem List (Pre-Intervention)Baseline (Pre-Intervention) Chart AuditThis outcome reflects whether a cancer diagnosis was documented on the patient's EHR problem list, consistent with survivorship care documentation standards. Charts were coded as Completed when the cancer diagnosis appeared in the structured problem list.
Cancer Diagnosis on Problem List (Post-Intervention)24-Month Follow-Up (Post-Intervention) Chart AuditThis outcome reflects whether a cancer diagnosis was documented on the patient's EHR problem list, consistent with survivorship care documentation standards. Charts were coded as Completed when the cancer diagnosis appeared in the structured problem list.
Family History of Cancer Documentation (Pre-Intervention)Baseline (Pre-intervention) Chart AuditFamily history of cancer documentation was defined as the presence of cancer-related family history information in the EHR. Charts were coded as Completed when documentation included a family history of cancer assessment entry.
Family History of Cancer Documentation (Post-Intervention)24-Month Follow-Up (Post-Intervention) Chart AuditFamily history of cancer documentation was defined as the presence of cancer-related family history information in the EHR. Charts were coded as Completed when documentation included a family history of cancer assessment entry.

Countries

United States

Participant flow

Recruitment details

Clinics were the unit of assignment. The intervention was delivered at the clinic level. Outcome data were collected through retrospective, de-identified EHR chart reviews. Participants represent chart abstractions for cancer survivors seen during two independent audit periods: a baseline (pre-intervention) chart audit and a 24-month post-intervention chart audit. These audit samples were drawn from the same participating clinics but do not represent the same individual cancer survivors.

Participants by arm

ArmCount
Baseline (Pre-Intervention) Chart Audit
This arm represents the baseline, pre-intervention chart audit sample drawn from participating primary care clinics prior to implementation of the KanSurvive ECHO + Practice Facilitation intervention. Charts included in this audit reflect an independent analytic sample of cancer survivors and do not necessarily represent the same individuals included in the baseline chart audit. Demographic characteristics were abstracted at this time point (Baseline) to describe the post-intervention sample. Analyses are descriptive and no inferential comparisons were conducted between baseline and post-intervention samples.
138
24-Month Follow-Up (Post-Intervention) Chart Audit
This arm represents the 24-month post-intervention chart audit sample drawn from the same participating primary care clinics following implementation of the KanSurvive ECHO + Practice Facilitation intervention. Charts included in this audit reflect an independent analytic sample of cancer survivors and do not necessarily represent the same individuals included in the baseline chart audit. Demographic characteristics were abstracted at this time point (Post) to describe the post-intervention sample. Analyses are descriptive and no inferential comparisons were conducted between baseline and post-intervention samples.
129
Total267

Baseline characteristics

CharacteristicBaseline (Pre-Intervention) Chart Audit24-Month Follow-Up (Post-Intervention) Chart AuditTotal
Age, Continuous64.5 years
STANDARD_DEVIATION 7.7
63.0 years
STANDARD_DEVIATION 9.6
63.8 years
STANDARD_DEVIATION 8.65
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants3 Participants6 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
121 Participants125 Participants246 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
14 Participants1 Participants15 Participants
Number of EHR charts analyzed at baseline138 EHR charts129 EHR charts267 EHR charts
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
2 Participants1 Participants3 Participants
Race (NIH/OMB)
Black or African American
2 Participants2 Participants4 Participants
Race (NIH/OMB)
More than one race
2 Participants0 Participants2 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants30 Participants32 Participants
Race (NIH/OMB)
White
130 Participants96 Participants226 Participants
Sex: Female, Male
Female
74 Participants67 Participants141 Participants
Sex: Female, Male
Male
64 Participants62 Participants126 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 00 / 0
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Body Mass Index (BMI) Assessment Completion (Post-Intervention)

BMI assessment was defined as documentation of a height and weight measurement sufficient to calculate body mass index (BMI) in the electronic health record (EHR). Charts were coded as Completed when BMI or its components were documented within the recommended timeframe.

Time frame: 24-Month Follow-Up (Post-Intervention) Chart Audit

Population: Analysis population includes all EHR charts meeting inclusion criteria with complete documentation for the specified time point. Differences in sample size between baseline and post-intervention reflect routine variation in chart availability and completeness across clinics

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
KanSurvive ECHO + Practice FacilitationBody Mass Index (BMI) Assessment Completion (Post-Intervention)118 Participants
Primary

Body Mass Index (BMI) Assessment Completion (Pre-Intervention)

BMI assessment was defined as documentation of a height and weight measurement sufficient to calculate body mass index (BMI) in the electronic health record (EHR). Charts were coded as Completed when BMI or its components were documented within the recommended timeframe.

Time frame: Baseline (Pre-intervention) Chart Review

Population: Analysis population includes all EHR charts meeting inclusion criteria with complete documentation for the specified time point. Differences in sample size between baseline and post-intervention reflect routine variation in chart availability and completeness across clinics

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
KanSurvive ECHO + Practice FacilitationBody Mass Index (BMI) Assessment Completion (Pre-Intervention)132 Participants
Comparison: Differences in cancer survivorship performance indicators and surveillance rates by tumor types before and after intervention were assessed using Fisher Exact tests.p-value: <0.05Fisher Exact
Primary

Cancer Diagnosis on Problem List (Post-Intervention)

This outcome reflects whether a cancer diagnosis was documented on the patient's EHR problem list, consistent with survivorship care documentation standards. Charts were coded as Completed when the cancer diagnosis appeared in the structured problem list.

Time frame: 24-Month Follow-Up (Post-Intervention) Chart Audit

Population: Analysis population includes all EHR charts meeting inclusion criteria with complete documentation for the specified time point. Differences in sample size between baseline and post-intervention reflect routine variation in chart availability and completeness across clinics

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
KanSurvive ECHO + Practice FacilitationCancer Diagnosis on Problem List (Post-Intervention)122 Participants
Primary

Cancer Diagnosis on Problem List (Pre-Intervention)

This outcome reflects whether a cancer diagnosis was documented on the patient's EHR problem list, consistent with survivorship care documentation standards. Charts were coded as Completed when the cancer diagnosis appeared in the structured problem list.

Time frame: Baseline (Pre-Intervention) Chart Audit

Population: Analysis population includes all EHR charts meeting inclusion criteria with complete documentation for the specified time point. Differences in sample size between baseline and post-intervention reflect routine variation in chart availability and completeness across clinics

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
KanSurvive ECHO + Practice FacilitationCancer Diagnosis on Problem List (Pre-Intervention)129 Participants
Comparison: Differences in cancer survivorship performance indicators and surveillance rates by tumor types before and after intervention were assessed using Fisher Exact tests.p-value: <0.05Fisher Exact
Primary

Distress Screening Completion (Post-Intervention)

This outcome reflects whether recommended Distress Screening was completed and documented in the EHR. Distress Screening was defined as documentation of using a standardized distress assessment tool consistent with survivorship best practices. Charts were coded as Completed when a distress screening result was documented during the chart abstraction interval. Not Complete indicated missing or incomplete documentation.

Time frame: 24-Month Follow-Up (Post-Intervention) Chart Audit

Population: Analysis population includes all EHR charts meeting inclusion criteria with complete documentation for the specified time point. Differences in sample size between baseline and post-intervention reflect routine variation in chart availability and completeness across clinics.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
KanSurvive ECHO + Practice FacilitationDistress Screening Completion (Post-Intervention)116 Participants
Primary

Distress Screening Completion (Pre-Intervention)

This outcome reflects whether recommended Distress Screening was completed and documented in the EHR. Distress Screening was defined as documentation of using a standardized distress assessment tool consistent with survivorship best practices. Charts were coded as Completed when a distress screening result was documented during the chart abstraction interval. Not Complete indicated missing or incomplete documentation.

Time frame: Baseline (Pre-intervention) Chart Review

Population: Analysis population includes all EHR charts meeting inclusion criteria with complete documentation for the specified time point. Differences in sample size between baseline and post-intervention reflect routine variation in chart availability and completeness across clinics

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
KanSurvive ECHO + Practice FacilitationDistress Screening Completion (Pre-Intervention)116 Participants
Comparison: Differences in cancer survivorship performance indicators and surveillance rates by tumor types before and after intervention were assessed using Fisher Exact tests.p-value: <0.05Fisher Exact
Primary

Family History of Cancer Documentation (Post-Intervention)

Family history of cancer documentation was defined as the presence of cancer-related family history information in the EHR. Charts were coded as Completed when documentation included a family history of cancer assessment entry.

Time frame: 24-Month Follow-Up (Post-Intervention) Chart Audit

Population: Analysis population includes all EHR charts meeting inclusion criteria with complete documentation for the specified time point. Differences in sample size between baseline and post-intervention reflect routine variation in chart availability and completeness across clinics.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
KanSurvive ECHO + Practice FacilitationFamily History of Cancer Documentation (Post-Intervention)115 Participants
Primary

Family History of Cancer Documentation (Pre-Intervention)

Family history of cancer documentation was defined as the presence of cancer-related family history information in the EHR. Charts were coded as Completed when documentation included a family history of cancer assessment entry.

Time frame: Baseline (Pre-intervention) Chart Audit

Population: Analysis population includes all EHR charts meeting inclusion criteria with complete documentation for the specified time point. Differences in sample size between baseline and post-intervention reflect routine variation in chart availability and completeness across clinics.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
KanSurvive ECHO + Practice FacilitationFamily History of Cancer Documentation (Pre-Intervention)96 Participants
Comparison: Differences in cancer survivorship performance indicators and surveillance rates by tumor types before and after intervention were assessed using Fisher Exact tests.p-value: <0.05Fisher Exact
Primary

Tobacco Use Screening Completion (Post-Intervention)

Tobacco use screening was defined as documentation of current tobacco use status in the electronic health record (EHR). Charts were coded as Completed when a screening result was documented within the recommended timeframe.

Time frame: 24-Month Follow-Up (Post-Intervention) Chart Audit

Population: Analysis population includes all EHR charts meeting inclusion criteria with complete documentation for the specified time point. Differences in sample size between baseline and post-intervention reflect routine variation in chart availability and completeness across clinics

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
KanSurvive ECHO + Practice FacilitationTobacco Use Screening Completion (Post-Intervention)119 Participants
Primary

Tobacco Use Screening Completion (Pre-Intervention)

Tobacco use screening was defined as documentation of current tobacco use status in the electronic health record (EHR). Charts were coded as Completed when a screening result was documented within the recommended timeframe.

Time frame: Baseline (Pre-Intervention) Chart Audit

Population: Analysis population includes all EHR charts meeting inclusion criteria with complete documentation for the specified time point. Differences in sample size between baseline and post-intervention reflect routine variation in chart availability and completeness across clinics

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
KanSurvive ECHO + Practice FacilitationTobacco Use Screening Completion (Pre-Intervention)115 Participants
Comparison: Differences in cancer survivorship performance indicators and surveillance rates by tumor types before and after intervention were assessed using Fisher Exact tests.p-value: <0.05Fisher Exact
Primary

Tumor Surveillance Completion (Post-Intervention)

This outcome reflects whether recommended tumor surveillance was completed and documented in the EHR. Tumor surveillance includes cancer-specific follow-up imaging consistent with evidence-based survivorship guidelines (e.g., NCCN, ASCO). Charts were coded as Completed if the recommended surveillance test was documented within the appropriate interval and Not Completed if documentation was absent, outdated, or incomplete. The outcome reports the proportion of EHR charts meeting tumor surveillance recommendations at baseline (pre-intervention) and again 24 months after the intervention.

Time frame: 24-Month Follow-Up (Post-Intervention) Chart Audit

Population: Analysis population includes all EHR charts meeting inclusion criteria with complete documentation for the specified time point. Differences in sample size between baseline and post-intervention reflect routine variation in chart availability and completeness across clinics.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
KanSurvive ECHO + Practice FacilitationTumor Surveillance Completion (Post-Intervention)117 Participants
Primary

Tumor Surveillance Completion (Pre-Intervention)

This outcome reflects whether recommended tumor surveillance was completed and documented in the EHR. Tumor surveillance includes cancer-specific follow-up imaging consistent with evidence-based survivorship guidelines (e.g., NCCN, ASCO). Charts were coded as Completed if the recommended surveillance test was documented within the appropriate interval and Not Completed if documentation was absent, outdated, or incomplete. The outcome reports the proportion of EHR charts meeting tumor surveillance recommendations at baseline (pre-intervention) and again 24 months after the intervention.

Time frame: Baseline (Pre-Intervention) Chart Audit

Population: Analysis population includes all EHR charts meeting inclusion criteria with complete documentation for the specified time point. Differences in sample size between baseline and post-intervention reflect routine variation in chart availability and completeness across clinics

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
KanSurvive ECHO + Practice FacilitationTumor Surveillance Completion (Pre-Intervention)126 Participants
Comparison: Differences in cancer survivorship performance indicators and surveillance rates by tumor types before and after intervention were assessed using Fisher Exact tests.p-value: <0.05Chi-squared

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026